PUBLICATIONS MÉDICALES
L’activité scientifique des néphrologues du centre a toujours été importante depuis les années 90. Les médecins ont fait de nombreuses communications dans les congrès nationaux et internationaux, mais aussi des publications dans des revues internationales dont nous ne citerons que quelques-unes des dernières parutions.
Chazot, C., C. Vo-Van, et al. (2011) « Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. » l Nephrol Dial Transplant 26(8): 2630-2634
Jean, G. (2011). « How to manage mineral metabolism disorders in renal failure. » l Presse Med 40(11): 1043-1052.
Jean, G., J. C. Souberbielle, et al. (2012). « Clinical and biological forms of secondary hyperparathyroidism in dialysis patients. »l Nephrol Ther 8(1): 35-40.
Jean, G., J. C. Souberbielle, et al. (2012). « Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease. » l Clin Biochem 45(6): 436-439.
Jean, G. and T. Vanel (2011). « Phosphate binders in a European haemodialysis population. » l Nephrol Dial Transplant 26(6): 2057-2058; author reply 2058.
Chazot, C. and G. Jean (2010). « Intradialytic hypertension: it is time to act. » l Nephron Clin Pract 115(3): c182-188.
Jean, G. and C. Chazot (2010). « The French clinician’s guide to the Kidney disease […] » l Nephrol Ther 6(3): 151-157.
Jean, G., T. Vanel, et al. (2010). « Non-infected central venous catheters in hemodialysis patients are not associated with inflammation. » l Kidney Int 78(7): 709; author reply 709-710.
Jean, G., T. Vanel, et al. (2010). « Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. » l Hemodial Int 14(4): 486-491.
Chazot, C., G. Jean, et al. (2009). « The plasma level of brain natriuretic peptide is increased in malnourished hemodialysis patients. » l Blood Purif 28(3): 187-192.
Jean, G., E. Bresson, et al. (2009). « Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. » l Nephrol Dial Transplant 24(3): 948-955.
Jean, G., J. C. Souberbielle, et al. (2009). « Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. »l Nephrol Dial Transplant 24(12): 3799-3805.
Jean, G., J. C. Terrat, et al. (2009). « High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. » l Nephrol Dial Transplant 24(9): 2792-2796.
Jean, G., T. Vanel, et al. (2009). « Treating mineral metabolism disorders in patients undergoing long hemodialysis: a search for an optimal strategy. » l Hemodial Int 13(4): 526-532.
Chazot, C. and G. Jean (2008). « Treatment time. » l Contrib Nephrol 161: 154-161.
Jean, G., B. Charra, et al. (2008). « Vitamin D deficiency and associated factors in hemodialysis patients. » l J Ren Nutr 18(5): 395-399.